Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENA-001 respiratory pharmacodynamics with propofol under hypoxia and hypercapnia
NL-OMON50050Active, not recruiting
- Sponsor
- Enalare Therapeutics
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hypopnea and respiratory failure comparing ENA-001 + propofol sequence with Placebo + propofol sequence (2 arms). Primary endpoints: Safety and tolerability, Minute ventilation response and 2 more. Started Sep 2021; status: active, not recruiting.
02
Drugs
ENA-001propofol
03
Conditions
hypopnearespiratory failure
Beyond the preview
Go deeper on NL-OMON50050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50050.